BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11861837)

  • 1. Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression.
    Furuta RA; Sugiura K; Kawakita S; Inada T; Ikehara S; Matsuda T; Fujisawa J
    J Virol; 2002 Mar; 76(6):2703-13. PubMed ID: 11861837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.
    Ohashi T; Hanabuchi S; Kato H; Tateno H; Takemura F; Tsukahara T; Koya Y; Hasegawa A; Masuda T; Kannagi M
    J Virol; 2000 Oct; 74(20):9610-6. PubMed ID: 11000233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
    Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
    Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1.
    Jiang S; Inada T; Tanaka M; Furuta RA; Shingu K; Fujisawa J
    Retrovirology; 2009 Aug; 6():73. PubMed ID: 19664292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
    Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
    Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
    Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
    Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latency Reversing Agents: Kick and Kill of HTLV-1?
    Schnell AP; Kohrt S; Thoma-Kress AK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
    Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
    Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
    Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
    Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
    Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S
    Cancer Sci; 2018 Aug; 109(8):2383-2390. PubMed ID: 29845702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
    Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
    J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.
    Nomura M; Ohashi T; Nishikawa K; Nishitsuji H; Kurihara K; Hasegawa A; Furuta RA; Fujisawa J; Tanaka Y; Hanabuchi S; Harashima N; Masuda T; Kannagi M
    J Virol; 2004 Apr; 78(8):3827-36. PubMed ID: 15047798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
    Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
    Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
    Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.